US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
US4366241A
(en)
|
1980-08-07 |
1982-12-28 |
Syva Company |
Concentrating zone method in heterogeneous immunoassays
|
US4517288A
(en)
|
1981-01-23 |
1985-05-14 |
American Hospital Supply Corp. |
Solid phase system for ligand assay
|
US4702909A
(en)
|
1982-05-05 |
1987-10-27 |
Louisiana State University A & M |
Non-A, non-B hepatitis antigen, antigen compositions, vaccine and diagnostic reagent
|
CA1291031C
(en)
|
1985-12-23 |
1991-10-22 |
Nikolaas C.J. De Jaeger |
Method for the detection of specific binding agents and their correspondingbindable substances
|
US5231000A
(en)
|
1987-10-08 |
1993-07-27 |
The Mclean Hospital |
Antibodies to A4 amyloid peptide
|
US5118606A
(en)
|
1988-09-02 |
1992-06-02 |
The Regents Of The University Of California |
Methods for detecting cellular pathology by assaying spectrin and spectrin breakdown products
|
US5234814A
(en)
|
1989-06-01 |
1993-08-10 |
Du Pont Merck Pharmaceutical Company |
Diagnostic assay for alzheimer's disease
|
US5118937A
(en)
|
1989-08-22 |
1992-06-02 |
Finnigan Mat Gmbh |
Process and device for the laser desorption of an analyte molecular ions, especially of biomolecules
|
US5045694A
(en)
|
1989-09-27 |
1991-09-03 |
The Rockefeller University |
Instrument and method for the laser desorption of ions in mass spectrometry
|
CA2077665A1
(en)
|
1990-03-05 |
1991-09-06 |
Robert Siman |
Chymotrypsin-like proteases and their inhibitors
|
US5586226A
(en)
|
1990-05-16 |
1996-12-17 |
Canon Kabushiki Kaisha |
Control method and device for a unicolor printer
|
US5496938A
(en)
|
1990-06-11 |
1996-03-05 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands to HIV-RT and HIV-1 rev
|
KR970002255B1
(ko)
|
1990-06-11 |
1997-02-26 |
넥스스타 파아마슈티컬드, 인크. |
핵산 리간드
|
US5270163A
(en)
*
|
1990-06-11 |
1993-12-14 |
University Research Corporation |
Methods for identifying nucleic acid ligands
|
US5637459A
(en)
|
1990-06-11 |
1997-06-10 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chimeric selex
|
US5707796A
(en)
|
1990-06-11 |
1998-01-13 |
Nexstar Pharmaceuticals, Inc. |
Method for selecting nucleic acids on the basis of structure
|
US6011020A
(en)
*
|
1990-06-11 |
2000-01-04 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligand complexes
|
US5567588A
(en)
|
1990-06-11 |
1996-10-22 |
University Research Corporation |
Systematic evolution of ligands by exponential enrichment: Solution SELEX
|
US5660985A
(en)
|
1990-06-11 |
1997-08-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands containing modified nucleotides
|
US5683867A
(en)
*
|
1990-06-11 |
1997-11-04 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: blended SELEX
|
US5252463A
(en)
*
|
1990-06-22 |
1993-10-12 |
The Du Pont Merck Pharmaceutical Company |
Clipsin, a chymotrypsin-like protease and method of using same
|
WO1993003369A1
(en)
|
1991-08-01 |
1993-02-18 |
Voorheis Paul H |
Diagnostic method for alzheimer's disease
|
WO1993024834A1
(en)
|
1992-05-29 |
1993-12-09 |
The Rockefeller University |
Method and product for the sequence determination of peptides using a mass spectrometer
|
US5792664A
(en)
|
1992-05-29 |
1998-08-11 |
The Rockefeller University |
Methods for producing and analyzing biopolymer ladders
|
ATE242485T1
(de)
|
1993-05-28 |
2003-06-15 |
Baylor College Medicine |
Verfahren und massenspektrometer zur desorption und ionisierung von analyten
|
DE4337654C2
(de)
|
1993-11-04 |
1996-08-08 |
Biotest Pharma Gmbh |
Verwendung boviner Kolostralmilch von nicht mit Viren hyperimmunisierten Tieren als Leberschutzpräparat
|
US5536639A
(en)
*
|
1994-03-25 |
1996-07-16 |
Cephalon, Inc. |
Methods for detecting calpain activation by detection of calpain activated spectrin breakdown products
|
WO1996002634A1
(en)
|
1994-07-15 |
1996-02-01 |
Cephalon, Inc. |
Active calpain expressed by baculovirus
|
US5614649A
(en)
|
1994-11-14 |
1997-03-25 |
Cephalon, Inc. |
Multicatalytic protease inhibitors
|
US5777194A
(en)
*
|
1995-04-26 |
1998-07-07 |
Cephalon, Inc. |
Gene-targeted mice with humanized Aβ sequence and Swedish FAD mutation
|
CA2246072A1
(en)
|
1996-02-02 |
1997-08-07 |
Biotrin Intellectual Properties Limited |
Method of determining the hepatic status of an individual, including a liver transplant recipient
|
US6048703A
(en)
*
|
1996-11-15 |
2000-04-11 |
Cephalon, Inc. |
Methods for detecting cell apoptosis
|
NZ516848A
(en)
|
1997-06-20 |
2004-03-26 |
Ciphergen Biosystems Inc |
Retentate chromatography apparatus with applications in biology and medicine
|
CA2314259A1
(en)
|
1997-12-16 |
1999-06-24 |
Robert Siman |
Multicatalytic protease inhibitors for use as anti-tumor agents
|
IL138668A0
(en)
|
1998-04-03 |
2001-10-31 |
Phylos Inc |
Addressable protein arrays
|
US6406921B1
(en)
|
1998-07-14 |
2002-06-18 |
Zyomyx, Incorporated |
Protein arrays for high-throughput screening
|
AU772151B2
(en)
|
1998-09-08 |
2004-04-08 |
Innogenetics N.V. |
Tau as a marker for early CNS damage
|
AU4025300A
(en)
|
1999-03-24 |
2000-10-09 |
Packard Bioscience Company |
Continuous porous matrix arrays
|
US6218005B1
(en)
*
|
1999-04-01 |
2001-04-17 |
3M Innovative Properties Company |
Tapes for heat sealing substrates
|
US20020002270A1
(en)
|
1999-06-16 |
2002-01-03 |
Raymond P. Zinkowski |
Purified antigen for alzheimer's disease, and methods of obtaining and using same
|
US6589746B1
(en)
|
1999-10-21 |
2003-07-08 |
University Of Cincinnati |
Method of detecting axonally-derived protein tau in patients with traumatic CNS injury
|
WO2001075165A2
(en)
*
|
2000-03-30 |
2001-10-11 |
Elan Pharmaceuticals, Inc. |
Screening markers and methods for neurodegenerative disorders
|
US20050063942A1
(en)
|
2001-02-02 |
2005-03-24 |
Clark Mike A. |
Methods for predicting sensitivity of tumors to arginine deprivation
|
US6949377B2
(en)
|
2001-03-05 |
2005-09-27 |
Ho Winston Z |
Chemiluminescence-based microfluidic biochip
|
US20040203083A1
(en)
|
2001-04-13 |
2004-10-14 |
Biosite, Inc. |
Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
|
US20040253637A1
(en)
|
2001-04-13 |
2004-12-16 |
Biosite Incorporated |
Markers for differential diagnosis and methods of use thereof
|
US7713705B2
(en)
|
2002-12-24 |
2010-05-11 |
Biosite, Inc. |
Markers for differential diagnosis and methods of use thereof
|
US20030199000A1
(en)
|
2001-08-20 |
2003-10-23 |
Valkirs Gunars E. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
US20020172676A1
(en)
|
2001-05-16 |
2002-11-21 |
George Jackowski |
Method of treatment of alzheimer's disease and device therefor
|
US7144708B2
(en)
|
2001-06-25 |
2006-12-05 |
The Cleveland Clinic Foundation |
Markers of blood barrier disruption and methods of using same
|
JP2003070498A
(ja)
|
2001-07-19 |
2003-03-11 |
Pharma Design Inc |
ユビキチンカルボキシルターミナルヒドロラーゼl1遺伝子異常の検出方法
|
CA2457775A1
(en)
*
|
2001-08-20 |
2003-02-27 |
Biosite Incorporated |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
US20030040660A1
(en)
|
2001-08-27 |
2003-02-27 |
George Jackowski |
Method for diagnosing and distinguishing traumatic brain injury and diagnostic devices for use therein
|
WO2003032894A2
(en)
|
2001-10-12 |
2003-04-24 |
Pfizer Products Inc. |
Method of monitoring neuroprotective treatment
|
WO2003062824A1
(en)
|
2002-01-23 |
2003-07-31 |
Boditech Inc. |
Lateral flow quantitative assay method and strip and laser-induced fluoerescence detection device therefor
|
WO2003064624A2
(en)
|
2002-01-31 |
2003-08-07 |
Gene Logic, Inc. |
Molecular hepatotoxicology modeling
|
WO2003085083A2
(en)
|
2002-04-01 |
2003-10-16 |
Phase-1 Molecular Toxicology, Inc. |
Liver necrosis predictive genes
|
AU2003243563A1
(en)
|
2002-06-12 |
2004-09-28 |
The Cleveland Clinic Foundation |
Markers of blood barrier permeability and methods of using same
|
JP2005538380A
(ja)
*
|
2002-09-11 |
2005-12-15 |
ユニヴァーシティ オヴ フロリダ |
神経細胞損傷の分析
|
JP2006526140A
(ja)
|
2002-12-24 |
2006-11-16 |
バイオサイト インコーポレイテッド |
鑑別診断のためのマーカーおよびその使用方法
|
WO2005004794A2
(en)
|
2003-06-09 |
2005-01-20 |
Alnylam Pharmaceuticals Inc. |
Method of treating neurodegenerative disease
|
GB0322063D0
(en)
*
|
2003-09-20 |
2003-10-22 |
Univ Geneve |
Diagnostic method for brain damage-related disorders
|
EP2341350B1
(en)
|
2003-09-20 |
2017-11-08 |
Electrophoretics Limited |
Diagnostic method for brain damage-related disorders based on detection of dj-1
|
EP1519194A1
(en)
|
2003-09-24 |
2005-03-30 |
Roche Diagnostics GmbH |
Use of gfap for identification of intracerebral hemorrhage
|
US20050130226A1
(en)
|
2003-09-26 |
2005-06-16 |
The University Of Cincinnati |
Fully integrated protein lab-on-a-chip with smart microfluidics for spot array generation
|
US7794948B2
(en)
|
2003-11-07 |
2010-09-14 |
Vermilllion, Inc. |
Biomarkers for alzheimer's disease
|
US20060094064A1
(en)
|
2003-11-19 |
2006-05-04 |
Sandip Ray |
Methods and compositions for diagnosis, stratification, and monitoring of alzheimer's disease and other neurological disorders in body fluids
|
US20050112585A1
(en)
|
2003-11-21 |
2005-05-26 |
Dominic Zichi |
Method for adjusting the quantification range of individual analytes in a multiplexed assay
|
TWI281473B
(en)
|
2003-12-19 |
2007-05-21 |
Ind Tech Res Inst |
Biomarkers for liver diseases and method for using same
|
EP1704405A1
(en)
|
2003-12-31 |
2006-09-27 |
The President and Fellows of Harvard College |
Assay device and method
|
AU2005245785B2
(en)
|
2004-04-15 |
2011-04-07 |
Banyan Biomarkers Inc. |
Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
|
JP4659025B2
(ja)
*
|
2004-04-15 |
2011-03-30 |
ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド |
神経系傷害および他の神経障害についての生物マーカーとしての神経タンパク質
|
US8492107B2
(en)
|
2004-04-15 |
2013-07-23 |
University Of Florida Research Foundation, Inc. |
Neural proteins as biomarkers for nervous system injury and other neural disorders
|
US20140303041A1
(en)
|
2004-04-15 |
2014-10-09 |
University Of Florida Research Foundation Inc. |
In vitro diagnostic devices for nervous system injury and other neural disorders
|
US20060292558A1
(en)
|
2004-07-19 |
2006-12-28 |
Cell Biosciences Inc. |
Methods and apparatus for protein assay diagnostics
|
WO2006042734A1
(de)
|
2004-10-15 |
2006-04-27 |
Siemens Aktiengesellschaft |
Verfahren zur durchführung einer elektrochemischen messung an einer flüssigen messprobe in einer über leitungen zugänglichen messkammer und zugehörige anordnung
|
US8048638B2
(en)
|
2005-04-01 |
2011-11-01 |
University Of Florida Research Foundation, Inc. |
Biomarkers of liver injury
|
JP5202296B2
(ja)
|
2005-04-01 |
2013-06-05 |
ユニバーシティ オブ フロリダ リサーチ ファウンデーション,インコーポレイティド |
肝臓傷害のバイオマーカー
|
GB2428240A
(en)
|
2005-07-14 |
2007-01-24 |
Univ Gen Ve |
Diagnostic method for brain damage-related disorders
|
US20070074972A1
(en)
|
2005-09-13 |
2007-04-05 |
Fluidigm Corporation |
Microfluidic assay devices and methods
|
WO2007046811A2
(en)
|
2005-10-20 |
2007-04-26 |
Biosite, Inc. |
Diagnostic markers of stroke and cerebral injury and methods of use thereof
|
JP5507085B2
(ja)
|
2006-01-12 |
2014-05-28 |
マイクロラボ ピーティーワイ エルティーディー |
新しい計装システム及び方法
|
WO2007094395A1
(ja)
|
2006-02-15 |
2007-08-23 |
Mie University |
診断用組換えプロテオリポソームの作製法
|
US20070255113A1
(en)
|
2006-05-01 |
2007-11-01 |
Grimes F R |
Methods and apparatus for identifying disease status using biomarkers
|
WO2007136617A2
(en)
|
2006-05-18 |
2007-11-29 |
Walter Reed Army Institute Of Research (Wrair) |
Endothelial-monocyte activating polypeptide ii, a biomarker for use in diagnosis of brain injury
|
EP2024395A4
(en)
|
2006-05-26 |
2009-07-01 |
Biosite Inc |
USE OF NATRIURETIC PEPTIDES AS DIAGNOSTIC AND PROGNOSTIC INDICATORS IN VASCULAR DISEASES
|
WO2008008819A2
(en)
|
2006-07-11 |
2008-01-17 |
University Of Florida Research Foundation, Inc. |
Diagnosis and treatment of neurological inflammation
|
WO2008063369A2
(en)
|
2006-11-01 |
2008-05-29 |
George Mason Intellectual Properties, Inc. |
Biomarkers for neurological conditions
|
US8293489B2
(en)
|
2007-01-31 |
2012-10-23 |
Henkin Robert I |
Methods for detection of biological substances
|
WO2008097618A1
(en)
|
2007-02-06 |
2008-08-14 |
University Of Florida Research Foundation, Inc. |
Synaptotagmin and collapsin response mediator protein as biomarkers for traumatic brain injury
|
US20120196307A1
(en)
|
2007-02-06 |
2012-08-02 |
Banyan Biomarkers, Inc. |
Synaptotagmin and collapsin response mediator protein as biomarkers for traumatic brain injury
|
JP2011511301A
(ja)
|
2008-02-04 |
2011-04-07 |
バンヤン・バイオマーカーズ・インコーポレイテッド |
脳損傷を診断または治療するための方法
|
CN102065894B
(zh)
|
2008-04-17 |
2013-06-19 |
班扬生物标记公司 |
一种含有活性剂分子的抗体结合的合成囊泡
|
EP2143735A1
(en)
|
2008-07-10 |
2010-01-13 |
Institut Pasteur |
Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
|
WO2010019553A2
(en)
|
2008-08-11 |
2010-02-18 |
Banyan Biomarkers, Inc. |
Biomarker detection process and assay of neurological condition
|
US20140342381A1
(en)
|
2008-08-11 |
2014-11-20 |
Banyan Biomarkers, Inc. |
Devices and methods for biomarker detection process and assay of neurological condition
|
WO2010033912A2
(en)
|
2008-09-19 |
2010-03-25 |
Henry Ford Health System |
Methods, systems, and compositions for calpain inhibition
|
US20120094295A1
(en)
|
2008-11-21 |
2012-04-19 |
The Johns Hopkins University |
Neurodegenerative disease diagnostic compositions and methods of use
|
US20170315136A9
(en)
|
2009-06-19 |
2017-11-02 |
Banyan Biomarkers, Inc. |
Biomarker assay of neurological condition
|
WO2010148391A2
(en)
|
2009-06-19 |
2010-12-23 |
Banyan Biomarkers, Inc. |
Biomarker assay of neurological condition
|
WO2011011334A2
(en)
|
2009-07-18 |
2011-01-27 |
Banyan Biomarkers, Inc. |
SYNERGISTIC BIOMARKER ASSAY OF NEUROLGICAL CONDITION USING S-100β
|
EP2478360B1
(en)
|
2009-09-14 |
2018-06-27 |
Banyan Biomarkers, Inc. |
Autoantibody markers for diagnosis of traumatic brain injury
|
EP2531224B1
(en)
|
2010-01-26 |
2019-06-05 |
Bioregency, Inc. |
Compositions and methods relating to argininosuccinate synthetase
|
CN102918397A
(zh)
|
2010-04-01 |
2013-02-06 |
班扬生物标记公司 |
用于神经毒性检测的标志物和测定方法
|
WO2011160096A2
(en)
|
2010-06-17 |
2011-12-22 |
Banyan Biomarkers, Inc. |
Glial fibrillary acidic protein, autoantigens and autoantibodies thereto as biomarkers of neural injury or neurological disorder or condition
|
WO2012051519A2
(en)
|
2010-10-14 |
2012-04-19 |
The Johns Hopkins University |
Biomarkers of brain injury
|
JP6061935B2
(ja)
|
2011-09-14 |
2017-01-18 |
ザ ヘンリー エム. ジャクソン ファウンデーション フォー ザ アドバンスメント オブ ミリタリー メディシン,インコーポレーテッド |
心的外傷後ストレス障害(ptsd)のための診断用バイオマーカーを検出及び監視するため、並びに同障害の自殺型と非自殺型とを識別するためのプロセス及びキット
|
US20140018299A1
(en)
|
2012-07-10 |
2014-01-16 |
Banyan Biomarkers, Inc. |
Method and device to detect, monitor and promote neural regeneration and improvement of cognitive function in a subject suffering from neural injury
|
US20140024053A1
(en)
|
2012-07-20 |
2014-01-23 |
Banyan Biomarkers, Inc. |
Methods, kits and devices for detecting bii-spectrin, and breakdown products thereof, as biomarkers for the diagnosis of neural injury
|
US20140275294A1
(en)
|
2013-03-15 |
2014-09-18 |
Banyan Biomarkers, Inc. |
Devices and methods for biomarker detection process and assay of liver injury
|
WO2014194329A1
(en)
|
2013-05-31 |
2014-12-04 |
Banyan Biomarkers, Inc. |
NEURAL SPECIFIC S100β FOR BIOMARKER ASSAYS AND DEVICES FOR DETECTION OF A NEUROLOGICAL CONDITION
|
CN106461645A
(zh)
|
2014-04-07 |
2017-02-22 |
铁马诊断公司 |
外伤性脑损伤和神经退行性生物标记物、方法和系统
|
CN106605146B
(zh)
|
2014-04-08 |
2020-07-28 |
佛罗里达大学研究基金会有限公司 |
用于中枢神经系统的急性、亚急性和慢性创伤性损伤的蛋白质标志物
|
EP3532496A1
(en)
|
2016-10-28 |
2019-09-04 |
Banyan Biomarkers, Inc. |
Antibodies to ubiquitin c-terminal hydrolase l1 (uch-l1) and glial fibrillary acidic protein (gfap) and related methods
|
WO2018191531A1
(en)
*
|
2017-04-15 |
2018-10-18 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury in a human subject using early biomarkers
|
WO2018200823A1
(en)
*
|
2017-04-28 |
2018-11-01 |
Abbott Laboratories |
Methods for aiding in the hyperacute diagnosis and determination of traumatic brain injury using early biomarkers on at least two samples from the same human subject
|
US11129564B2
(en)
*
|
2017-05-30 |
2021-09-28 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a mild traumatic brain injury in a human subject using cardiac troponin I
|
JP7344801B2
(ja)
*
|
2017-12-09 |
2023-09-14 |
アボット・ラボラトリーズ |
グリア原線維性酸性タンパク質(gfap)及び/又はユビキチンカルボキシ末端ヒドロラーゼl1(uch-l1)を使用する、整形外科損傷を負っており、軽度外傷性脳損傷(tbi)などの頭部への損傷を負ったか又は負った可能性がある対象についての診断及び査定の一助となるための方法
|
WO2019112860A1
(en)
*
|
2017-12-09 |
2019-06-13 |
Abbott Laboratories |
Methods for aiding in diagnosing and evaluating a traumatic brain injury in a human subject using a combination of gfap and uch-l1
|